GH Cochin Broca Hôtel-Dieu
Welcome,         Profile    Billing    Logout  
 14 Trials 
18 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ALEXANDRE, Jérôme
DOMENICA, NCT05201547 / 2021-002124-21: Endometrial Cancer Patientes MMR Deficient Comparing Chemotherapy vs Dostarlimab in First Line

Recruiting
3
260
Europe, Canada, Japan, RoW
Carboplatin-Paclitaxel, Dostarlimab
ARCAGY/ GINECO GROUP, GlaxoSmithKline
Endometrial Cancer
04/26
10/29
NIRVANA-1, NCT05183984 / 2021-004278-76: Niraparib with BeVAcizumab After Complete CytoreductioN in Patients with OvArian Cancer

Recruiting
2
390
Europe, Japan, RoW
Chemotherapy, Bevacizumab-Awwb, Niraparib
ARCAGY/ GINECO GROUP, GSK
Ovarian Cancer
02/27
02/30
TEDOVA, NCT04713514 / 2020-004364-25: OSE2101 Alone or in Combination With Pembrolizumab vs BSC in Patient With Platinum-sensitive Recurrent OC

Active, not recruiting
2
180
Europe
OSE2101, TEDOPI®, Pembrolizumab 25 MG/ML [Keytruda], KEYTRUDA®, MK-3475
ARCAGY/ GINECO GROUP, OSE Immunotherapeutics, Merck Sharp & Dohme LLC
Platinum-sensitive Ovarian Cancer, Relapsed Ovarian Cancer
12/25
12/25
KELI-PAOLA, NCT06660147: Validation of KELIM as a Predictive/Prognostic Factor for Maintenance Treatment With iPARP in First-Line Ovarian Cancer

Recruiting
N/A
327
Europe, RoW
ARCAGY/ GINECO GROUP
Ovarian Cancer
12/24
12/24
ctDNA-endo, NCT05955079: Circulating Tumor DNA Study in Patients With Endometrial Cancer

Recruiting
N/A
130
Europe
Whole blood
Assistance Publique - Hôpitaux de Paris, CARPEM, Institut du Cancer Paris, Centre de recherche des Cordeliers, METHYS DX
Endometrial Cancer
10/24
01/26
KURTZ, Jean-Emmanuel
PREPARE, NCT02704832: Role of Geriatric Intervention in Treatment of Older Patients With Cancer

Active, not recruiting
3
792
Europe
Geriatrician Intervention
Institut Bergonié, Ministry of Health, France
Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Bladder Cancer, Ovarian Cancer, Lymphoma
12/23
03/26
ATALANTE, NCT02891824 / 2015-005471-24: Atezolizumab vs Placebo Phase III Study in Late Relapse Ovarian Cancer Treated With Chemotherapy+Bevacizumab

Checkmark Presentation of data from ATALANTE trial for 3L ovarian cancer at ESMO 2022
Sep 2022 - Sep 2022: Presentation of data from ATALANTE trial for 3L ovarian cancer at ESMO 2022
Completed
3
614
Europe, RoW
atezolizumab + avastin + platinum-based chemotherapy, Tecentriq, placebo + avastin + platinum-based chemotherapy
ARCAGY/ GINECO GROUP, Hoffmann-La Roche
Ovarian Cancer
10/21
02/24
CIRSARC, NCT03805022 / 2018-000186-36: Benefit of Intensified Peri-operative Chemotherapy Within High-risk CINSARC Patients With Resectable Soft-tissue Sarcomas

Recruiting
3
351
Europe
Doxorubicin, Ifosfamide or dacarbazine, At the discretion of the investigator
Institut Bergonié, Novartis, Chugai Pharma France
Non-metastatic Soft-tissue Sarcoma, Resectable
02/25
02/25
ImadGist, NCT02260505 / 2013-001372-37: Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST)

Completed
3
136
Europe
Imatinib maintenance, Glivec, Imatinib mésilate
Centre Leon Berard, INCA
Gastrointestinal Stromal Tumors, Resected Gastrointestinal Stromal Tumors, Non-metastatic, High Risk of Recurrence, KIT Gene Mutation
12/23
12/23
EREMISS, NCT03793361: Phase II Study of Regorafenib as Maintenance Therapy

Completed
2
127
Europe
Regorafenib, stivarga, Placebo
Centre Oscar Lambret
Metastatic Soft Tissue Sarcoma
03/24
09/24
L-UteCIN, NCT06524583: Interest of Post-operative Chemotherapy in Patients With Localised Uterine Leiomyosarcoma Suspected of Having a High Risk of Recurrence Based on a Biological Test Performed on the Tumour

Recruiting
2
198
Europe
Doxorubicin, Trabectedin, Yondelis
UNICANCER, PharmaMar, Ligue contre le cancer, France, National Research Agency, France, University Hospital, Marseille, Institut Claudius Regaud, Institut Bergonié, Oncopole
Leiomyosarcoma Uterus
12/29
12/30
ETIOSARC, NCT03670927: Etiosarc: Environmental Aetiology of Sarcomas From a Multicenter French Population-based Case-control Study Among Adults

Completed
N/A
2237
Europe
Environmental, occupational and lifestyle-related exposures
Institut National de la Santé Et de la Recherche Médicale, France
Sarcoma, Environmental Exposure, Occupational Exposure, Life Style
07/24
07/24
SCARA-B, NCT06443645: Role of Sodium-glucose Linked Transporter 2 (SGLT2) and Its Inhibitor Over CARdiotoxicity Induced by Anthracyclines and Breast Cancer Tumorigenesis

Recruiting
N/A
50
Europe
Anthracycline
Institut de cancérologie Strasbourg Europe
Breast Neoplasms
12/26
12/26
CRYODESMO-02, NCT06081400: Cryoablation Versus Medical Therapy in Desmoid Tumors Progressing After Watchful Waiting

Recruiting
N/A
150
Europe
Cryoablation, Chemotherapy drug
University Hospital, Strasbourg, France, Direction Générale de l'Offre des Soins (DGOS)
Desmoid Tumor
03/27
06/29
OPTISARC, NCT05272358: Economic Evaluation of Sarcoma Patients Management in France

Recruiting
N/A
2431
Europe
NETSARC network
Centre Leon Berard, École nationale supérieure des Mines Saint-Etienne France, Rennes University Hospital, Assistance Publique - Hôpitaux de Paris
Sarcoma
06/22
02/24
OnKO-TnT-1-0, NCT05617131: Cell Phone Application to Help Adolescents and Young Adults in Their Therapeutic and Educational Journey

Recruiting
N/A
60
Europe
University Hospital, Strasbourg, France
Cancer
12/23
12/23
COCK, Laure DE
ImadGist, NCT02260505 / 2013-001372-37: Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST)

Completed
3
136
Europe
Imatinib maintenance, Glivec, Imatinib mésilate
Centre Leon Berard, INCA
Gastrointestinal Stromal Tumors, Resected Gastrointestinal Stromal Tumors, Non-metastatic, High Risk of Recurrence, KIT Gene Mutation
12/23
12/23
CHACRY-1501, NCT02871167: Risk of Infertility Related to Adjuvant Chemotherapy for Early Breast Cancer: Oocyte/Embryo Cryopreservation

Active, not recruiting
N/A
140
Europe
Controlled ovarian hyperstimulation (COH), Oocyte/embryo freezing
Centre Oscar Lambret, University Hospital, Lille, National Cancer Institute, France, University Hospital, Montpellier
Breast Cancer
06/24
11/34
DINXH-XUAN, Anh Tuan
No trials found
TRA, Thi-Tuyet-Suong
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ALEXANDRE, Jérôme
DOMENICA, NCT05201547 / 2021-002124-21: Endometrial Cancer Patientes MMR Deficient Comparing Chemotherapy vs Dostarlimab in First Line

Recruiting
3
260
Europe, Canada, Japan, RoW
Carboplatin-Paclitaxel, Dostarlimab
ARCAGY/ GINECO GROUP, GlaxoSmithKline
Endometrial Cancer
04/26
10/29
NIRVANA-1, NCT05183984 / 2021-004278-76: Niraparib with BeVAcizumab After Complete CytoreductioN in Patients with OvArian Cancer

Recruiting
2
390
Europe, Japan, RoW
Chemotherapy, Bevacizumab-Awwb, Niraparib
ARCAGY/ GINECO GROUP, GSK
Ovarian Cancer
02/27
02/30
TEDOVA, NCT04713514 / 2020-004364-25: OSE2101 Alone or in Combination With Pembrolizumab vs BSC in Patient With Platinum-sensitive Recurrent OC

Active, not recruiting
2
180
Europe
OSE2101, TEDOPI®, Pembrolizumab 25 MG/ML [Keytruda], KEYTRUDA®, MK-3475
ARCAGY/ GINECO GROUP, OSE Immunotherapeutics, Merck Sharp & Dohme LLC
Platinum-sensitive Ovarian Cancer, Relapsed Ovarian Cancer
12/25
12/25
KELI-PAOLA, NCT06660147: Validation of KELIM as a Predictive/Prognostic Factor for Maintenance Treatment With iPARP in First-Line Ovarian Cancer

Recruiting
N/A
327
Europe, RoW
ARCAGY/ GINECO GROUP
Ovarian Cancer
12/24
12/24
ctDNA-endo, NCT05955079: Circulating Tumor DNA Study in Patients With Endometrial Cancer

Recruiting
N/A
130
Europe
Whole blood
Assistance Publique - Hôpitaux de Paris, CARPEM, Institut du Cancer Paris, Centre de recherche des Cordeliers, METHYS DX
Endometrial Cancer
10/24
01/26
KURTZ, Jean-Emmanuel
PREPARE, NCT02704832: Role of Geriatric Intervention in Treatment of Older Patients With Cancer

Active, not recruiting
3
792
Europe
Geriatrician Intervention
Institut Bergonié, Ministry of Health, France
Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Bladder Cancer, Ovarian Cancer, Lymphoma
12/23
03/26
ATALANTE, NCT02891824 / 2015-005471-24: Atezolizumab vs Placebo Phase III Study in Late Relapse Ovarian Cancer Treated With Chemotherapy+Bevacizumab

Checkmark Presentation of data from ATALANTE trial for 3L ovarian cancer at ESMO 2022
Sep 2022 - Sep 2022: Presentation of data from ATALANTE trial for 3L ovarian cancer at ESMO 2022
Completed
3
614
Europe, RoW
atezolizumab + avastin + platinum-based chemotherapy, Tecentriq, placebo + avastin + platinum-based chemotherapy
ARCAGY/ GINECO GROUP, Hoffmann-La Roche
Ovarian Cancer
10/21
02/24
CIRSARC, NCT03805022 / 2018-000186-36: Benefit of Intensified Peri-operative Chemotherapy Within High-risk CINSARC Patients With Resectable Soft-tissue Sarcomas

Recruiting
3
351
Europe
Doxorubicin, Ifosfamide or dacarbazine, At the discretion of the investigator
Institut Bergonié, Novartis, Chugai Pharma France
Non-metastatic Soft-tissue Sarcoma, Resectable
02/25
02/25
ImadGist, NCT02260505 / 2013-001372-37: Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST)

Completed
3
136
Europe
Imatinib maintenance, Glivec, Imatinib mésilate
Centre Leon Berard, INCA
Gastrointestinal Stromal Tumors, Resected Gastrointestinal Stromal Tumors, Non-metastatic, High Risk of Recurrence, KIT Gene Mutation
12/23
12/23
EREMISS, NCT03793361: Phase II Study of Regorafenib as Maintenance Therapy

Completed
2
127
Europe
Regorafenib, stivarga, Placebo
Centre Oscar Lambret
Metastatic Soft Tissue Sarcoma
03/24
09/24
L-UteCIN, NCT06524583: Interest of Post-operative Chemotherapy in Patients With Localised Uterine Leiomyosarcoma Suspected of Having a High Risk of Recurrence Based on a Biological Test Performed on the Tumour

Recruiting
2
198
Europe
Doxorubicin, Trabectedin, Yondelis
UNICANCER, PharmaMar, Ligue contre le cancer, France, National Research Agency, France, University Hospital, Marseille, Institut Claudius Regaud, Institut Bergonié, Oncopole
Leiomyosarcoma Uterus
12/29
12/30
ETIOSARC, NCT03670927: Etiosarc: Environmental Aetiology of Sarcomas From a Multicenter French Population-based Case-control Study Among Adults

Completed
N/A
2237
Europe
Environmental, occupational and lifestyle-related exposures
Institut National de la Santé Et de la Recherche Médicale, France
Sarcoma, Environmental Exposure, Occupational Exposure, Life Style
07/24
07/24
SCARA-B, NCT06443645: Role of Sodium-glucose Linked Transporter 2 (SGLT2) and Its Inhibitor Over CARdiotoxicity Induced by Anthracyclines and Breast Cancer Tumorigenesis

Recruiting
N/A
50
Europe
Anthracycline
Institut de cancérologie Strasbourg Europe
Breast Neoplasms
12/26
12/26
CRYODESMO-02, NCT06081400: Cryoablation Versus Medical Therapy in Desmoid Tumors Progressing After Watchful Waiting

Recruiting
N/A
150
Europe
Cryoablation, Chemotherapy drug
University Hospital, Strasbourg, France, Direction Générale de l'Offre des Soins (DGOS)
Desmoid Tumor
03/27
06/29
OPTISARC, NCT05272358: Economic Evaluation of Sarcoma Patients Management in France

Recruiting
N/A
2431
Europe
NETSARC network
Centre Leon Berard, École nationale supérieure des Mines Saint-Etienne France, Rennes University Hospital, Assistance Publique - Hôpitaux de Paris
Sarcoma
06/22
02/24
OnKO-TnT-1-0, NCT05617131: Cell Phone Application to Help Adolescents and Young Adults in Their Therapeutic and Educational Journey

Recruiting
N/A
60
Europe
University Hospital, Strasbourg, France
Cancer
12/23
12/23
COCK, Laure DE
ImadGist, NCT02260505 / 2013-001372-37: Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST)

Completed
3
136
Europe
Imatinib maintenance, Glivec, Imatinib mésilate
Centre Leon Berard, INCA
Gastrointestinal Stromal Tumors, Resected Gastrointestinal Stromal Tumors, Non-metastatic, High Risk of Recurrence, KIT Gene Mutation
12/23
12/23
CHACRY-1501, NCT02871167: Risk of Infertility Related to Adjuvant Chemotherapy for Early Breast Cancer: Oocyte/Embryo Cryopreservation

Active, not recruiting
N/A
140
Europe
Controlled ovarian hyperstimulation (COH), Oocyte/embryo freezing
Centre Oscar Lambret, University Hospital, Lille, National Cancer Institute, France, University Hospital, Montpellier
Breast Cancer
06/24
11/34
DINXH-XUAN, Anh Tuan
No trials found
TRA, Thi-Tuyet-Suong
No trials found

Download Options